Publication:
Invasive Streptococcus Pyogenes: A Short Literature Review

dc.authorscopusid59663612400
dc.authorscopusid57210265515
dc.authorwosidTanriverdi Cayci, Yeliz/Aaa-5191-2020
dc.authorwosidAltindis, Mustafa/O-8413-2019
dc.contributor.authorCayci, Yeliz Tanriverdi
dc.contributor.authorAltindis, Mustafa
dc.contributor.authorIDTanriverdi Çaycı, Yeliz/0000-0002-9251-1953
dc.date.accessioned2025-12-11T01:09:50Z
dc.date.issued2024
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Cayci, Yeliz Tanriverdi] Ondokuz Mayis Univ, Fac Med, Dept Med Microbiol, Samsun, Turkiye; [Altindis, Mustafa] Sakarya Univ, Fac Med, Dept Med Microbiol, Sakarya, Turkiye; [Cayci, Yeliz Tanriverdi] Ondokuz Mayis Univ, Fac Med, Dept ofMed Microbiol, Turkiye, TR-55320 Samsun, Turkiyeen_US
dc.descriptionTanriverdi Çaycı, Yeliz/0000-0002-9251-1953;en_US
dc.description.abstractObjective Streptococcus pyogenes also called Group A streptococci (GAS) is an important pathogen known since past years and infects millions of people around the world every year and can cause death. Although it often causes pharyngitis and skin infections, it can also spread to the bloodstream and cause invasive GAS (iGAS) infections. In this review, studies on the epidemiology of GAS and iGAS and vaccine studies were reviewed. Methods A comprehensive search of databases was conducted up to April 1, 2023 to related studies, in English using the following terms: S. pyogenes, GAS, invasive S. pyogenes infections, iGAS, S. pyogenes vaccine. The data extraction was conducted by two investigators using the same methodology. Results There has been an increase in iGAS infections in various countries in the last year and they have been followed closely. Although the reason for the increase in iGAS cases cannot be determined exactly, it is thought that the recent removal of coronavirus disease 2019 restrictions and the increase in the number of individuals susceptible to GAS and to viral respiratory pathogens is thought to have caused this situation. Another important issue with GAS is the vaccine studies. Vaccines are based on two different targets: M protein-based and non-M protein-based. Phase-I clinical trials have been initiated for some vaccines. Conclusion The increase in recent iGAS infections will draw attention to this agent and accelerate vaccine studies.en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.doi10.1055/s-0043-1772740
dc.identifier.endpage10en_US
dc.identifier.issn1305-7707
dc.identifier.issn1305-7693
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85170852360
dc.identifier.scopusqualityQ4
dc.identifier.startpage1en_US
dc.identifier.urihttps://doi.org/10.1055/s-0043-1772740
dc.identifier.urihttps://hdl.handle.net/20.500.12712/41747
dc.identifier.volume19en_US
dc.identifier.wosWOS:001065239900001
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherGeorg Thieme Verlag Kgen_US
dc.relation.ispartofJournal of Pediatric Infectious Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectStreptococcus Pyogenesen_US
dc.subjectInvasiveen_US
dc.subjectVaccineen_US
dc.subjectIgAsen_US
dc.titleInvasive Streptococcus Pyogenes: A Short Literature Reviewen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files